Provided By PR Newswire
Last update: Jul 12, 2025
NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:EWTX (9/8/2025, 12:20:32 PM)
15.1
-0.47 (-3.02%)
Find more stocks in the Stock Screener